Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2018 | Sutro Biopharma | $85.0M Series E | Samsara BioCapital, Surveyor Capital | Advent Life Sciences, Alta Partners, Amgen Ventures, Celgene, Eventide Asset Management, Lilly Ventures, Merck, Skyline Ventures, SV Health Investors, Tekla Capital Management, Vida Ventures |